Neuroprotective effects of vitamin D and 17ß-estradiol against ovariectomy-induced neuroinflammation and depressive-like state: Role of the AMPK/NF-κB pathway

Wen-yuan Zhang,Yu-jin Guo,Ke-yi Wang,Lin-mu Chen,Pei Jiang
DOI: https://doi.org/10.1016/j.intimp.2020.106734
IF: 5.714
2020-09-01
International Immunopharmacology
Abstract:<p>Estrogen replacement therapy (ERT) has been proven to relieve menopausal-related mental disorders including depression in postmenopausal women. However, the unsafety of ERT hinders its clinical use. In this study, we would evaluate whether vitamin D (VD), a hormone with optimal safety profile, could relieve the depressive-like symptom in ovariectomized (OVX) rats. Furthermore, we would determine whether vitamin D and 17β-estradiol (E2) exert neurological function through their immunomodulatory effect in OVX rats. Middle-aged female SD rats were randomly divided into four groups, namely, control (SHAM), OVX, OVX + VD, and OVX + E2. Vitamin D (calcitriol, 100 ng/kg) and 17β-estradiol (30 μg/kg) had been daily gavaged in the OVX + VD and OVX + E2 group, respectively. After 10-week administration, vitamin D and 17β-estradiol both showed anti-depressive-like activity in the OVX rats. Using the method of immunofluorescent staining and western blot, vitamin D and 17β-estradiol were demonstrated to upregulate each other's receptors, including VDR, ERα, and ERβ in the hippocampus of OVX rats. Additionally, the upregulation of VDR, calbindin-D28k, and calbindin-D9k suggested that the vitamin D signaling system was amplified by vitamin D and 17β-estradiol. Vitamin D and 17β-estradiol showed neuroprotective effects by decreasing OVX-induced apoptosis and neuronal damage, regulating the AMPK/NF-κB signaling pathway, and reducing the proinflammatory cytokines (IL-1β, IL-6, and TNFα), as well as iNOS and COX-2 in the hippocampus of OVX rats. Collectively, the present study demonstrated that vitamin D and 17β-estradiol could upregulate each other's receptors and regulate the AMPK/NF-κB pathway to relieve the OVX-induced depressive-like state. The results could stimulate translational research towards the vitamin D potential for prevention or treatment of menopause-related depression.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore whether Vitamin D (VD) and 17β-estradiol (E2) can alleviate depressive-like behavior in ovariectomized rats (OVX rats) through the regulation of neuroinflammation and to investigate their potential mechanisms. Specifically, the paper addresses the following aspects: 1. **Alleviation of Depressive-like Behavior**: - Investigate whether Vitamin D and 17β-estradiol can alleviate depressive-like behavior in OVX rats. - Discover that both exhibit antidepressant-like activity. 2. **Receptor Upregulation**: - The study finds that Vitamin D and 17β-estradiol can upregulate each other's receptors in the hippocampus of OVX rats, including Vitamin D receptor (VDR), estrogen receptor α (ERα), and estrogen receptor β (ERβ). 3. **Neuroprotective Effects**: - The research shows that Vitamin D and 17β-estradiol can exert neuroprotective effects by reducing OVX-induced apoptosis and neuronal damage. - Specifically, this is manifested by a reduction in the number of apoptotic cells and an increase in the number of surviving neurons in the hippocampus. 4. **Regulation of Signaling Pathways**: - The study finds that Vitamin D and 17β-estradiol can alleviate neuroinflammation by regulating the AMPK/NF-κB signaling pathway. - Specifically, this is manifested by the inhibition of NF-κB protein levels, increased expression of IκB protein, and enhanced p-AMPK/AMPK ratio. 5. **Reduction of Inflammatory Factors**: - The research finds that Vitamin D and 17β-estradiol can reduce the expression of pro-inflammatory cytokines (such as IL-1β, IL-6, and TNFα), as well as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in the hippocampus. Through these findings, the authors suggest that Vitamin D and 17β-estradiol may alleviate OVX-induced depressive-like behavior through neuroinflammation regulatory mechanisms, providing new research directions for the prevention and treatment of menopausal depression.